Strategy decks are comforting. They imply clarity. They rarely imply evidence — especially evidence about whether the organization can execute what the deck proposes in the landscape it will face.
We increasingly start engagements with diagnostics before strategy design: SAiGE™ for AI transformation contexts, CIR for innovation architecture, SIR for venture readiness. The sequence is deliberate. Design without diagnosis is guesswork with formatting.
Clients resist the sequence for understandable reasons. Boards want direction. Teams want momentum. Diagnostics feel like delay. In practice, diagnostics compress decision time later — because they eliminate false debates about what is broken.
A regional financial institution spent six months in deadlock on AI investment. Diagnostic evidence replaced opinion in forty-eight hours. The strategy did not change arbitrarily — it changed because the premise finally matched reality.
If your next planning cycle begins with a deck, ask what evidence would need to exist for that deck to be true. That question is the diagnostic. Answer it before you design.
